June 2023 Publications
- Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. Choi YH, Kang YA, Park KJ, Choi JC, Cho KG, Ko DY, Ahn JH, Lee B, Ahn E, Woo YJ, Jung K, Kim NY, Reese VA, Larsen SE, Baldwin SL, Reed SG, Coler RN, Lee H, Cho SN. Infect Dis Ther. 2023 Jun. doi: 10.1007/s40121-023-00806-0. Epub 2023 May 11.
- Stressed stability and protective efficacy of lead lyophilized formulations of ID93+GLA-SE tuberculosis vaccine. Archer MC, McCollum J, Press C, Dutill TS, Liang H, Fedor D, Kapilow-Cohen L, Gerhardt A, Phan T, Trappler EH, Orr MT, Kramer RM, Fox CB. Heliyon. 2023 Jun. doi: 10.1016/j.heliyon.2023.e17325. Epub 2023 Jun 19.
- Liposomal delivery system/adjuvant for tuberculosis vaccine. Moradi M, Vahedi F, Abbassioun A, Ramezanpour Shahi A, Sholeh M, Taheri-Anganeh M, Dargahi Z, Ghanavati R, Khatami SH, Movahedpour A. Immun Inflamm Dis. 2023 Jun. doi: 10.1002/iid3.867.
- The immunogenetics of tuberculosis (TB) susceptibility. Ndong Sima CAA, Smith D, Petersen DC, Schurz H, Uren C, Möller M. Immunogenetics. 2023 Jun. doi: 10.1007/s00251-022-01290-5. Epub 2022 Dec 13.
- Demonstrating multi-country calibration of a tuberculosis model using new history matching and emulation package – hmer. Scarponi D, Iskauskas A, Clark RA, Vernon I, McKinley TJ, Goldstein M, Mukandavire C, Deol A, Weerasuriya C, Bakker R, White RG, McCreesh N. Epidemics. 2023 Jun. doi: 10.1016/j.epidem.2023.100678. Epub 2023 Mar 7.
- Synthesis of plant-based, self-adjuvanted, dual antigen specific to Mycobacterium tuberculosis as a novel tuberculosis subunit vaccine that elicits immunogenicity in rabbit. Yadav J, Phogat S, Chaudhary D, Jaiwal R, Jaiwal PK. Biotechnol Lett. 2023 Jun. doi: 10.1007/s10529-023-03371-1. Epub 2023 Apr 19
- A multi-stage and multi-epitope vaccine against Mycobacterium tuberculosis based on an immunoinformatics approach. Ning Y, Cai Y, Liu X, Gu C, Meng X, Qiao J. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2023 Jun. [Chinese].
- Genetic epidemiology of resistance to M. tuberculosis infection: importance of study design and recent findings. Stein CM. Genes Immun. 2023 Jun. doi: 10.1038/s41435-023-00204-z.
- Improving the profile and reliability of cytoplasmic proteins from M. tuberculosis using biomimetic affinity chromatography coupled with LC-MS/MS analysis. Ma G, Luo P, Xu R, Ma R, Qiu L, Xu C, Yang R, Li Y, Zhao Z, Huang L, Yang Y, Wang P. J Chromatogr B Analyt Technol Biomed Life Sci. 2023 Jun 1. doi: 10.1016/j.jchromb.2023.123756. Epub 2023 May 19.
- Role of non-coding RNAs in tuberculosis and their potential for clinical applications. Jumat MI, Sarmiento ME, Acosta A, Chin KL. J Appl Microbiol. 2023 Jun 1. doi: 10.1093/jambio/lxad104.
- Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration. Zhang C, Berg A, Joe CCD, Dalby PA, Douglas AD. NPJ Vaccines. 2023 Jun 5. doi: 10.1038/s41541-023-00674-2.
- Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in Africa. Kana BD, Arbuthnot P, Botwe BK, Choonara YE, Hassan F, Louzir H, Matsoso P, Moore PL, Muhairwe A, Naidoo K, Ndomondo-Sigonda M, Madhi SA. Lancet Infect Dis. 2023 Jun 5. doi: 10.1016/S1473-3099(22)00878-7. Epub ahead of print.
- End tuberculosis by 2035: challenges ahead. Malik AA, Sinha S, Ehtesham NZ, Hasnain SE. Future Microbiol. 2023 Jun 7. doi: 10.2217/fmb-2023-0056. Online ahead of print.
- Evolution of the Bacillus Calmette-Guérin scar Russia and Moreau strains in newborns: A brazilian cohort. Andrade de Souza R, Rodrigues Barreto F, Antônio de Souza Teles Santos C, Silva Nery J, Cristina Oliveira de Jesus Lima C, Soares Castelo I, Natividade M, Amaral Freire de Andrade J, Lima Barreto M, Martins Pereira S. Vaccine X. 2023 Jun 7. doi: 10.1016/j.jvacx.2023.100323.
- ESAT-6 a Major Virulence Factor of Mycobacterium tuberculosis. Anes E, Pires D, Mandal M, Azevedo-Pereira JM. EBiomolecules. 2023 Jun 9. doi: 10.3390/biom13060968.
- Practical considerations for a TB controlled human infection model (TB-CHIM); the case for TB-CHIM in Africa, a systematic review of the literature and report of 2 workshop discussions in UK and Malawi. Gordon SB, Sichone S, Chirwa AE, Hazenberg P, Kafuko Z, Ferreira DM, Flynn J, Fortune S, Balasingam S, Biagini GA, McShane H, Mwandumba HC, Jambo K, Dedha K, Raj Sharma N, Robertson BD, Walker NF, Morton B; TB Controlled Human Infection Model Development Group. Wellcome Open Res. 2023 Jun 12. doi: 10.12688/wellcomeopenres.18767.2.
- BCG∆BCG1419c and BCG differ in induction of autophagy, c-di-GMP content, proteome, and progression of lung pathology in Mycobacterium tuberculosis HN878-infected male BALB/c mice. Aceves-Sánchez MJ, Barrios-Payán JA, Segura-Cerda CA, Flores-Valdez MA, Mata-Espinosa D, Pedroza-Roldán C, Yadav R, Saini DK, de la Cruz MA, Ares MA, Bielefeldt-Ohmann H, Baay-Guzmán G, Vergne I, Velázquez-Fernández JB, Barba León J, Hernández-Pando R. Vaccine. 2023 Jun 13. doi: 10.1016/j.vaccine.2023.04.065. Epub 2023 May 8.
- Immunogenicity and efficacy analyses of EPC002, ECA006, and EPCP009 protein subunit combinations as tuberculosis vaccine candidates. Wang R, Fan X, Jiang Y, Li G, Li M, Zhao X, Luan X, Deng Y, Chen Z, Liu H, Wan K. Vaccine. 2023 Jun 13. doi: 10.1016/j.vaccine.2023.04.003.
- Airway T cells are a correlate of i.v. Bacille Calmette-Guerin-mediated protection against tuberculosis in rhesus macaques. Darrah PA, Zeppa JJ, Wang C, Irvine EB, Bucsan AN, Rodgers MA, Pokkali S, Hackney JA, Kamath M, White AG, Borish HJ, Frye LJ, Tomko J, Kracinovsky K, Lin PL, Klein E, Scanga CA, Alter G, Fortune SM, Lauffenburger DA, Flynn JL, Seder RA, Maiello P, Roederer M. Cell Host Microbe. 2023 Jun 14. doi: 10.1016/j.chom.2023.05.006. Epub 2023 Jun 1.
- Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how? Nelson KN, Churchyard G, Cobelens F, Hanekom WA, Hill PC, Lopman B, Mave V, Rangaka MX, Vekemans J, White RG, Wong EB, Martinez L, García-Basteiro AL. Lancet Microbe. 2023 Jun 14. doi: 10.1016/S2666-5247(23)00112-X. Online ahead of print.
- BCG: From veins to correlates. Suliman, S. Cell Host Microbe. 2023 Jun 14. doi: 10.1016/j.chom.2023.05.021.
- Prospective Subunit Nanovaccine against Mycobacterium tuberculosis Infection─Cubosome Lipid Nanocarriers of Cord Factor, Trehalose 6,6′ Dimycolate. Sarkar S, Mishra A, Periasamy S, Dyett B, Dogra P, Ball AS, Yeo LY, White JF, Wang Z, Cristini V, Jagannath C, Khan A, Soni SK, Drummond CJ, Conn CE. ACS Appl Mater Interfaces. 2023 Jun 14. doi: 10.1021/acsami.3c04063.
- High Lethality of Mycobacterium tuberculosis Infection in Mice Lacking the Phagocyte Oxidase and Caspase1/11. Thomas SM, Olive AJ. Infect Immun. 2023 Jun 14. doi: 10.1128/iai.00060-23. Epub ahead of print.
- Mycobacterial Genetic Technologies for Probing the Host-Pathogen Microenvironment. Adefisayo OO, Curtis ER, Smith CM. Infect Immun. 2023 Jun 15. doi: 10.1128/iai.00430-22. Epub 2023 May 30.
- Poly(ADP-ribose) polymerase 9 mediates early protection against Mycobacterium tuberculosis infection by regulating type I IFN production. Thirunavukkarasu S, Ahmed M, Rosa BA, Boothby M, Cho SH, Rangel-Moreno J, Mbandi SK, Schreiber V, Gupta A, Zuniga J, Mitreva M, Kaushal D, Scriba TJ, Khader SA. J Clin Invest. 2023 Jun 15. doi: 10.1172/JCI158630.
- Vaccines in Children Exposed to Biological Agents In Utero and/or During Breastfeeding: Are They Effective and Safe? Gisbert JP, Chaparro M. J Crohns Colitis. 2023 Jun 16. doi: 10.1093/ecco-jcc/jjad005.
- Attenuated Mycobacterium tuberculosis vaccine protection in a low-dose murine challenge model. Vidal SJ, Sellers D, Yu J, Wakabayashi S, Sixsmith J, Aid M, Barrett J, Stevens SF, Liu X, Li W, Plumlee CR, Urdahl KB, Martinot AJ, Barouch DH. iScience. 2023 Jun 16. doi: 10.1016/j.isci.2023.106963.
- Protection against tuberculosis achieved by dissolving microneedle patches loaded with live Mycobacterium paragordonae in a BCG prime-boost strategy. Lee MH, Seo H, Lee MS, Kim BJ, Kim HL, Lee DH, Oh J, Shin JY, Jin JY, Jeong DH, Kim BJ. Front Immunol. 2023 Jun 16. doi: 10.3389/fimmu.2023.1178688.
- Intravenous BCG Vaccination of Diversity Outbred Mice Results in Moderately Enhanced Protection against Challenge with Mycobacterium tuberculosis Compared to Intradermal Vaccination. Kurtz SL, Mittereder LR, Lehman CC, Khan H, Gould VA, Elkins KL. Infect Immun. 2023 Jun 20. doi: 10.1128/iai.001683-23. Online ahead of print.
- Effect of polycation coating on the long-term pulsatile release of antigenic ESAT-61-20 peptide from PLGA nanoparticles. Büyükbayraktar HK, Arayıcı PP, Ihlamur M, Gökkaya D, Karahan M, Abamor ES, Topuzoğulları M. Colloids Surf B Biointerfaces. 2023 Jun 20. doi: 10.1016/j.colsurfb.2023.Online ahead of print.
- Blood transcriptional correlates of BCG-induced protection against tuberculosis in rhesus macaques. Liu YE, Darrah PA, Zeppa JJ, Kamath M, Laboune F, Douek DC, Maiello P, Roederer M, Flynn JL, Seder RA, Khatri P. Cell Rep Med. 2023 Jun 20. doi: 10.1016/j.xcrm.2023.101096. Online ahead of print.
- Mycobacterium tuberculosis-Specific CD4 T Cells Expressing Transcription Factors T-Bet or RORγT Associate with Bacterial Control in Granulomas. Grant NL, Kelly K, Maiello P, Abbott H, O’Connor S, Lin PL, Scanga CA, Flynn JL. mBio. 2023 Jun 27. doi: 10.1128/mbio.00477-23. Epub 2023 Apr 11
- Promising tuberculosis vaccine gets US$550-million shot in the arm. Tozer L. Nature. 2023 Jun 28. doi: 10.1038/d41586-023-02171-x. Online ahead of print.
- Expanding global vaccine manufacturing capacity: Strategic prioritization in small countries. Mukherjee S, Kalra K, Phelan AL. PLOS Glob Public Health. 2023 Jun 29. doi: 10.1371/journal.pgph.0002098
- Leading from the frontlines: community-oriented approaches for strengthening vaccine delivery and acceptance. Dhaliwal BK, Seth R, Thankachen B, Qaiyum Y, Closser S, Best T, Shet A. BMC Proc. 2023 Jun 30. doi: 10.1186/s12919-023-00259-w.